Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, kguangzhou, GD, China.
Clin Exp Hypertens. 2022 Jul 4;44(5):451-458. doi: 10.1080/10641963.2022.2071914. Epub 2022 May 8.
To investigate the association between hypertension and clinical outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and invasive ventilation in patients with coronavirus disease 2019 (COVID-19) pneumonia.
We implemented a systematic search of PubMed for articles that assessed clinical outcomes of hypertensive patients infected with SARS-CoV-2. The primary outcomes evaluated included: in-hospital mortality, ICU admission, and the use of invasive ventilation.
A total of 18 studies were included, involving 13,293 patients and covering from January 25, 2020, to April 20, 2020. The relationship between hypertension and prognosis in COVID-19 patients was evaluated. Results showed that hypertension was a risk factor for in-hospital mortality in COVID-19 patients (RR: 2.20, 95% CI, 1.83-2.65, < .001). Moreover, patients with hypertension were more likely to be admitted to ICU (RR: 1.86, 95% CI, 1.13-3.07, = .001) and to use invasive ventilation (RR: 2.99, 95% CI, 1.73-5.17, < .001).
Among COVID-19 patients, those combined with hypertension had a significantly higher risk of in-hospital deaths, admission to ICU, and need for invasive ventilation.
为了研究高血压与新冠肺炎患者临床结局的相关性,包括院内死亡率、重症监护病房(ICU)入住率和有创性通气。
我们对 PubMed 进行了系统性检索,以评估感染 SARS-CoV-2 的高血压患者的临床结局。主要评估结局包括:院内死亡率、ICU 入住率和有创性通气的使用。
共纳入 18 项研究,涉及 13293 例患者,时间范围为 2020 年 1 月 25 日至 2020 年 4 月 20 日。评估了高血压与 COVID-19 患者预后之间的关系。结果表明,高血压是 COVID-19 患者院内死亡的危险因素(RR:2.20,95%CI,1.83-2.65,<0.001)。此外,高血压患者更有可能入住 ICU(RR:1.86,95%CI,1.13-3.07,=0.001)和需要有创性通气(RR:2.99,95%CI,1.73-5.17,<0.001)。
在 COVID-19 患者中,合并高血压的患者院内死亡、入住 ICU 和需要有创性通气的风险显著增加。